Inventors with similar research interests:
Location History:
- Bedford, MA (US) (1993)
- Topsfield, CA (US) (2007 - 2012)
- Topsfiled, MA (US) (2012)
- San Clemente, CA (US) (2012)
- Aurburndale, FL (US) (2017)
- Los Altos, CA (US) (2000 - 2018)
- Aburndale, FL (US) (2018)
- Topsfield, MA (US) (1994 - 2021)
- Middletown, RI (US) (2023)
- Auburndale, FL (US) (2015 - 2024)
- Nottingham, NH (US) (2024)
- Taunton, MA (US) (2024)
Company Filing History:
Years Active: 1993-2024
Areas of Expertise:
J. Christopher Flaherty is a well-known inventor with a knack for bringing innovative ideas to life. Based in Topsfield, MA, Flaherty has a whopping 233 patents to his name, making him a true pioneer in the field of inventions and patents.
His recent patents speak volumes about his ability to create groundbreaking, game-changing inventions that use state-of-the-art technology to change the world around us. One such patent is his Ultrasound sequencing system and method, which comprises a catheter configured for delivery to a body cavity defined by surrounding tissue, a plurality of ultrasound transducers coupled to a distal end of the catheter, and an electronics module configured to selectively turn on/off each ultrasound transducer according to a predetermined activation sequence. The system can process signals received from each ultrasound transducer to produce at least a 2D display of the surrounding tissue. A user can selectively calculate and display various aspects of cardiac activity. Moreover, the user can display Dipole Density (DDM), Charge Density (CDM), or Voltage (V-V). The shape and location of the chamber (surface), and the potentials recorded at electrodes can be displayed. The system can also change back and forth between the different display modes, and with post-processing tools, can change how various types of information is displayed.
Another one of Flaherty's patents is for methods, systems, and devices for reducing the luminal surface area of the gastrointestinal tract. These methods, systems, and devices for treating a patient include providing a tissue treatment element constructed and arranged to deliver energy to tissue and treating tissue of the gastrointestinal tract by causing the tissue treatment element to deliver energy to an energy delivery zone. Treatment results in a reduction in the luminal surface area of at least a portion of the gastrointestinal tract. In particular embodiments, the methods, systems and devices are used to treat diabetes.
Flaherty's contributions in the medical field have been nothing short of remarkable. He has worked for companies like ACUTUS MEDICAL, INC. and Fractyl Health, Inc., where he collaborated with talented individuals like Joshua Makower and Randell Louis Werneth.
It's clear that J. Christopher Flaherty has made a name for himself through his exceptional work in the field of inventions and patents. His contributions to the medical field have been truly remarkable. In fact, Flaherty's Ultrasound sequencing system and method and his methods, systems, and devices for reducing the luminal surface area of the gastrointestinal tract have the potential to revolutionize the medical industry as we know it.